CRO/Sponsor

The status of the CRO industry and doing business in the most recently emerged of the Asia-Pac regions.

FDA and EMA may issue new guidelines on sponsor-CRO governance and responsibilities.

Among the many clinical development processes that need to be conducted in a smarter, more cost-effective manner, clinical data monitoring stands out as a promising area in which operational efficiencies can not only reduce costs but also improve research quality and patient safety.

An overview of the clinical research landscape in this emerging region that also looks at its challenges.

A recent survey indicates pharmacists should provide more clinical trial information to patients.

There is still an endemic inefficiency in health care and clinical trial record connectivity.

New survey from Tufts CSDD and Applied Clinical Trials provides an inside look at global sites.

Step-by-step process for budgeting global trials that uses a Currency Risk Management method.

Guidance for auditing quality systems of independent ethics committees throughout Europe.

Even before trials start, compiling a "target label" can add value by helping steer product development.

Cultural, technological, and practical issues that need to be addressed to increase success.

Whether companies participate or idly observe community activity, this is a tactic worth considering.

Challenges and opportunities of integrating electronic data capture with electronic health records.

How different can the health care environments be from where data is derived to justify pooling?

Why models such as BRIDG are essential in developing clinical research processes and applications

Integration with other systems such as electronic trial management systems is EDC's future.

In-depth survey reveals trends, outlooks, and future plans of both sponsors and service providers.

The benefits of peer-to-peer networking over email, fax, FTP, and hosted solutions.

Sanofi Pasteur collects quality of life and safety data with eDiaries.

Clinical teams need to learn what motivates a patient to become a study subject.

The use of text messaging technology for recruitment in Phase I studies.

How an integrated, EDC-based system can optimize the endpoint process.

With clinical trials now a global industry, "back" translation requires a closer look.

Spending on research exceeds $35 billion, and clinical grant spending now tops $11 billion.

No one involved in clinical research is ever quite satisfied with the status quo.

There is a misalignment of experiences, expectations, and beliefs among subjects, investigators, sponsors, and service providers.

Systemized knowledge: experience, insight, and predictive modeling deliver successful enrollment.

Through digital signage, sponsors hope to increase enrollment in trials.

An intelligence-driven end-to-end approach defines new recruitment methods.

Promising data warehousing systems like Janus are still waiting to realize their potential.